Adaptive recruitment approach that incorporates patient feedback leads to higher enrollment rate and more engaged patients
Adaptive recruitment approach that incorporates patient feedback leads to higher enrollment rate and more engaged patients
SAN FRANCISCO - Dec. 17, 2019 - Recruiting patients for medical device trials is challenging due to longer trial durations and follow up periods, with nearly half of the trials unable to meet specified enrollment goals and 15 percent of sites unable to enroll a single patient. Leapcure, a technology pioneer in patient advocating trial services, today announces the expansion of its suite of trial services to the medical device industry, helping medical device companies with the successful recruitment, enrollment, and engagement of patients in clinical trials.
Leapcure’s services center on some of the biggest challenges facing Sponsors, Contract Research Organizations, and Investigator Sites, incorporating the patient voice to inform early development of studies. Services in clinical feasibility, site selection, public awareness, and recruitment have all been shown to increase enrollment rates leading to successful trials.
Its public awareness service now boasts a network of 3,500 health organizations, with 200 added recently, representing millions of patient voices and broaden the pool of participants significantly. This unprecedented level of access to patient communities is unique in the industry, increasing engagement between patients and researchers.
Leapcure’s protocol-level feasibility service assesses if a clinical trial’s goals are achievable and that trial requirements are designed with patients in mind. This minimizes study burden on patients and helps to determine the availability of study population.
Site selection is a critical component for trials, especially in medical device when the trials are inherently more complex. Leapcure incorporates recruitment viability, delivering the best experience for patients and identifying sites that will be effective recruitment partners.
The above coupled with Leapcure’s dynamic and adaptive recruitment services when enrollment opens has led to an impressive average refer to enroll ratio of 10:1, five times more efficient than other recruitment offerings. Traditional media buys and standalone social media ads can be as burdensome as 50:1. Adaptive recruitment always for real-time patient feedback that doesn’t pigeon-hole a sponsor into any one recruitment tactic, utilizing multiple communications strategies that absorb patient feedback, maintain trust and inform expectations for study participation.
“Using a multi-pronged approach to recruitment, we find the right patients for clinical studies and guide them through the recruitment process so everyone’s expectations are met. This is critical for ensuring a trial meets timelines and stays within budget, ” said Zach Gobst, CEO of Leapcure. “Ultimately, we make enrolling in a clinical trial easier for every party involved so that research funding is optimized and innovation moves forward.”
Leapcure ensures recruitment campaigns are conducted with accurately forecasted media budgets and performance results. Clinical teams see a savings of 75 percent, averaging $1 million saved per project, on recruitment tactics due to our ability to streamline and better target outreach once the trial is optimized for patient participation.
For more information, visit www.leapcure.com.
About Leapcure
Leapcure advances patient engagement in early clinical development with tech-enabled services for timely and cost effective recruitment, enrollment, and data aggregation. Founded in 2015 with offices in the US and EU, Leapcure partners with the world’s top Pharmaceutical Sponsors, Contract Research Organizations and Investigator Sites to deliver qualified patients faster and with a higher ROI. For more information, visit www.leapcure.com.
###
